Novozymes A/S (OTCMKTS:NVZMY) Posts Earnings Results, Misses Expectations By $0.16 EPS

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) posted its earnings results on Thursday. The biotechnology company reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.60 by ($0.16), Zacks reports. Novozymes A/S had a net margin of 14.70% and a return on equity of 6.60%. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.27 billion.

Novozymes A/S Stock Performance

OTCMKTS NVZMY opened at $70.09 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.67 and a quick ratio of 1.03. The stock’s 50 day simple moving average is $63.90 and its 200-day simple moving average is $60.65. The company has a market cap of $29.06 billion, a PE ratio of 44.36, a price-to-earnings-growth ratio of 3.30 and a beta of 0.92. Novozymes A/S has a 1-year low of $49.90 and a 1-year high of $75.27.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Zacks Research upgraded shares of Novozymes A/S from a “strong sell” rating to a “hold” rating in a research report on Monday, June 8th. Kepler Capital Markets upgraded shares of Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, May 13th. Two analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy”.

Get Our Latest Research Report on Novozymes A/S

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

Featured Stories

Earnings History for Novozymes A/S (OTCMKTS:NVZMY)

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.